
Opinion|Videos|June 19, 2024
Advancements in Alzheimer Disease Treatment: Emerging Drug Candidates
The panel discusses emerging therapies for Alzheimer disease that are currently in development, including donanemab, subcutaneous lecanemab, and ALZ-801.
Advertisement
Episodes in this series

Video content above is prompted by the following question(s):
- Could you discuss disease modifying and other therapies for Alzheimer disease that are currently in development?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Expands Upadacitinib Label for Treating Inflammatory Bowel Disease
2
CVS Pharmacy Completes Acquisition of Select Rite Aid Locations
3
ESMO Congress Marks 50 Years by Showcasing the Future of Cancer Care: Vivek Subbiah, MD
4
Medical School Diversity Declines Following Affirmative Action Repeal
5